Novartis (REGD) Dividend yield

Novartis (REGD) is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Novartis (REGD) is a company from Switzerland, and his stocks are publicly traded.

Novartis (REGD) stock dividend

Novartis (REGD) paid a total dividend of 6,736 million CHF last year, for a market value of 187,998 millions (Market Cap 179,976 millions). Novartis (REGD) dividend per share is 3.20 CHF, and his stock market price 89.31 CHF.

According to the chart below, where dividend yield is displayed, Novartis (REGD) has a dividend yield of 3.58%, which is higher than the amount offered by both the market average and companies from Switzerland. It is also bigger than average of Health Care industry. This high dividend yield might be a sign to worry about the future of the company so deeper analysis is needed.

In addition, you should compare Novartis (REGD) stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the highest Switzerland dividend stocks list.

Novartis (REGD) Dividend Payout

About the ability of Novartis (REGD) to maintain his current dividend of CHF 3.20 per share, an amount that accounts for 3.58%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Novartis (REGD) payout on ernings is currently 64.52%, which is higher than the market average, and companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures show that Novartis (REGD) can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Novartis (REGD) is CHF 6.43 per share, which is higher than the dividend per share paid by the company of CHF 3.20, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Novartis (REGD), compared againt world market average, Switzerland companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Novartis (REGD) Dividend History

Below you will find a table with the historical evolution of Novartis (REGD)'s dividend stock, both in percentage and in CHF, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	CHF	Paypout	Shares*
Present	3.58%	3.20	64.52%	2,105
2022	3.71%	3.10	25.96%	2,151
2021	3.74%	3.00	61.22%	2,205
2020	3.53%	2.95	68.76%	2,289
2019	3.10%	2.85	40.31%	2,241
2018	3.33%	2.80	58.33%	2,318
2017	3.34%	2.75	58.76%	2,364
2016	3.84%	2.70	32.69%	2,514
2015	2.96%	2.60	50.58%	2,369

*In millions

Then you can see the evolution of Novartis (REGD) dividend stock, and compare it with the average of Switzerland stocks and that of the Pharmaceuticals and Biotechnology stocks.

Novartis (REGD) Stock performance

Finally, last moth Novartis (REGD) showed a return of -1.90% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a 12.90% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for Switzerland and Pharmaceuticals and Biotechnology firms.